Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OpGen Assists 100K Genome Project

Published: Thursday, December 20, 2012
Last Updated: Thursday, December 20, 2012
Bookmark and Share
OpGen, Inc. has entered into a scientific and technical partnership with UC Davis in cooperation with the 100K Genome Project to create high resolution microbial genetic maps.

The 100K Genome Project is a collaboration that was initiated by the U.S. Food and Drug Administration (FDA), UC Davis, and Agilent Technologies to sequence the genetic code of at least 100,000 infectious organisms and accelerate the diagnosis of foodborne illnesses. UC Davis will integrate OpGen’s Argus Whole Genome Mapping System into its current DNA sequencing workflow for sequence assembly and validation of the genomes.

Through the integration of OpGen’s Whole Genome Mapping technology, The 100K Genome Project will create a new gold standard for high-quality microbial reference genomes. These data will be used in the surveillance and management of international foodborne microbial outbreaks, and to establish a high-fidelity global reference database for microbial genomes. The 100K Genome Project will publish the genomes that are completed and validated using OpGen’s Whole Genome Maps to a database, providing access to the genomic maps for public health agencies throughout the world. The FDA is advocating rigorous quality control standards for this reference database whereby genomic information should be validated by two independent methods.

“OpGen’s technology allows us to complete sequencing and provide quality control of genomes drafted by data produced using short read next-generation sequencing methods,” said Bart C. Weimer, Ph.D., Professor, Department of Population and Reproduction, School of Veterinary Medicine, University of California, Davis, and Director of The 100K Pathogen Genome Project. “Whole Genome Mapping provides an independent method to detect sequence variations and misassemblies, and aids us in closing the gaps. Final Whole Genome Maps will assist health agencies in outbreak management of food borne diseases which cause tremendous risk to public health.”

“We are pleased to be a partner in this collaboration with UC Davis and the FDA in helping to set a high-quality, validated standard for this important reference database of microbes, which pose the greatest threats to food safety and public health,” said Douglas White, Chief Executive Officer of OpGen. “OpGen is committed to advancing public health and providing actionable information to the healthcare community.”

The Centers for Disease Control and Prevention (CDC) estimates that each year roughly one in six Americans (or 48 million people) become sick, 128,000 are hospitalized, and 3,000 die of foodborne diseases.1 There are 31 known foodborne pathogens, including Salmonella, Listeria, and E. coli, among others.1 Many of these pathogens are tracked by public health systems that track diseases and outbreaks.1   Rapid identification and detection of these pathogens can lead to more effective control and management of microbial disease outbreaks.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OpGen and Hitachi Enter into an Agreement
The companies to develop offering that combines Whole Genome Mapping™ with cloud-based informatics and data management platforms.
Thursday, October 17, 2013
OpGen Announces Formation of Public Health Consortium
Consortium to evaluate whole genome mapping for improved genetic analysis of disease outbreaks.
Friday, May 18, 2012
OpGen Announces Strategic Collaboration with IQT
The collaboration is focused on developing a new high-throughput sequence and genome mapping pipeline for microbial genome analysis.
Tuesday, May 01, 2012
OpGen's Whole Genome Mapping System Features at International Plant & Animal Genome XX Conference
The company announced today that the company's new Whole Genome Mapping and Genome Builder(TM) software was featured in a poster session at the International Plant & Animal Genome XX Conference, January 14-18, 2012 in San Diego.
Tuesday, January 17, 2012
OpGen Strengthens Management Team to Accelerate Commercialization Strategy
Whole genome analysis company appoints new CIO and names key executive positions.
Thursday, December 22, 2011
OpGen Receives Frost & Sullivan New Product Innovation Award
OpGen, Inc. announces the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation for their Whole Genome Mapping System.
Wednesday, August 24, 2011
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!